Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 9/19/2020 7:00:00 PM
.@Apple's new #AppleWatch includes a blood oxygen reader: via @newscientist
BCH Innovation News @BCH_Innovation 9/19/2020 4:00:00 PM
Experimental #ALS medication shows promise of slowing down disease progression: via @harvardmed
BCH Innovation News @BCH_Innovation 9/19/2020 2:00:02 PM
Loss of BRG1 in #lungcancer affects the biochemical landscape of the replisome, increasing dependence on the ATR re…
BCH Innovation News @BCH_Innovation 9/18/2020 6:00:00 PM
New research explains how sleep apnea impacts heart health: via @HarvardHealth
BCH Innovation News @BCH_Innovation 9/18/2020 4:00:01 PM
Rapid antigen #COVID19 tests are being designed to enhance the speed in which health officials can determine if som…
BCH Innovation News @BCH_Innovation 9/18/2020 2:00:02 PM
BRG1-deficient lung cancers are sensitive to pharmacological inhibition of ATR, finds study in @CR_AACR. Findings c…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer